Measles resurgence in southern Africa: Challenges to measles elimination

Vaccine

Volumn 32, Issue 16, 2014, Pages 1798-1807

  Shibeshi, Messeret E ^a   Masresha, Balcha G ^a   Smit, Sheilagh B ^b   Biellik, Robin J ^c   Nicholson, Jennifer L ^d   Muitherero, Charles ^a   Shivute, Nestor ^a   Walker, Oladapo ^a   Reggis, Katsande ^a   Goodson, James L ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^c Measles and Rubella Regional Reference Laboratory National Institute of Communicable Diseases ^*  (Switzerland)

^d EMORY UNIVERSITY   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Africa; Elimination; Immunization; Measles; Vaccination

Indexed keywords

MCV 1; MEASLES VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROL STRATEGY; DISEASE ERADICATION; DISEASE SURVEILLANCE; EPIDEMIC; ERADICATION THERAPY; GENOTYPE; GROUPS BY AGE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NAMIBIA; PEDIATRICS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SOUTH AFRICA;

AFRICA; ELIMINATION; IMMUNIZATION; MEASLES; VACCINATION;

ADOLESCENT; ADULT; AFRICA, SOUTHERN; CHILD; CHILD, PRESCHOOL; DISEASE ERADICATION; DISEASE OUTBREAKS; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; MALE; MEASLES; MEASLES VACCINE; POPULATION SURVEILLANCE; VACCINATION; YOUNG ADULT;

EID: 84895889730     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.01.089     Document Type: Article

References (47)

1. Wolfson L.J., Strebel P.M., Gacic-Dobo M., et al. Has the 2005 measles mortality reduction goal been achieved?. A natural history modelling study. Lancet 2007, 369(9557):191-200.
2. Centers for Disease Control and Prevention Global control and regional elimination of measles, 2000-2011. MMWR 2013, 62(2):27-31.
3. World Health Organization. Global vaccine action plan 2011-2020. Geneva: World Health Organization; 2013. [accessed September 25, 2013]. http://www.who.int/immunization/global_vaccine_action_plan/GVAP_doc_2011_2020/en/index.html.
4. World Health Organization Regional Office for South-East Asia. Resolution of the WHO Regional Committee for South-East Asia. SEA/RC66/R5. Measles Elimination and Rubella/Congenital Rubella Syndrome Control; 2013.
5. de Quadros C.A., Olive J.M., Hersh B.S., et al. Measles elimination in the Americas, evolving strategies. JAMA 1996, 275(3):224-229.
6. Castillo-Solorzano C.C., Matus C.R., Flannery B., et al. The Americas: paving the road toward global measles eradication. J Infect Dis 2011, 204(Suppl. 1):S270-S278.
7. Castillo-Solorzano C., Marsigli C., Bravo-Alcantara P., et al. Elimination of rubella and congenital rubella syndrome in the Americas. J Infect Dis 2011, 204(Suppl. 2):S571-S578.
8. Centers for Disease Control and Prevention Progress toward control of rubella and prevention of congenital rubella syndrome-worldwide, 2009. MMWR 2010, 59(40):1307-1310.
9. Andrus J.K., de Quadros C.A., Solorzano C.C., Periago M.R., Henderson D.A. Measles and rubella eradication in the Americas. Vaccine 2011, 29(Suppl. 4):D91-D96.
10. Biellik R., Madema S., Taole A., et al. First 5 years of measles elimination in southern Africa: 1996-2000. Lancet 2002, 359(9317):1564-1568.
11. World Health Organization. WHO vaccine-preventable diseases: monitoring system 2013 global summary; 2013. [accessed July 8, 2013]. http://apps.who.int/immunization_monitoring/globalsummary.
12. World Health Organization World Health Assembly resolution WHA 56.20. Reducing global measles mortality 2003, World Health Organization, Geneva.
13. World Health Organization and UNICEF. Measles mortality reduction and regional elimination: strategic plan 2001-2005. Geneva: World Health Organization; 2003. [accessed July 8, 2013]. http://www.who.int/immunization-delivery/adc/measles/measles-strategic-plan.pdf.
14. World Health Organization Monitoring progress towards measles elimination. Wkly Epidemiol Rec 2010, 85(49):490-494.
15. World Health Organization Framework for verifying elimination of measles and rubella. Wkly Epidemiol Rec 2013, 88(9):89-99.
16. World Health Organization Global reductions in measles mortality 2000-2008 and the risk of measles resurgence. Wkly Epidemiol Rec 2009, 84(49):509-516.
17. World Health Organization African Regional Office, Resolution AFR/RC61/14. 61st Session of the WHO regional committee for Africa: Towards the elimination of measles in the African Region by 2020; 2011. [accessed March 1, 2013]. http://www.afro.who.int/en/sixty-first-session.html.
18. World Health Organization, Centers for Disease Control and Prevention Technical guidelines integrated disease surveillance and response in the African region 2010, 398. World Health Organization, Brazzaville, Republic of Congo/Atlanta, USA. 2nd ed.
19. Tamura K., Peterson D., Peterson N., et al. MEGA5: Molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739.
20. Centers for Disease Control and Prevention. Final report to the Ministry of Health-Malawi. Technical assistance for the 2009-2010 nationwide measles outbreak from the United States Centers for Disease Control and Prevention; 2011.
21. Centers for Disease Control and Prevention. Namibia measles outbreak, 2009-2011. Report of epidemiologic investigation; 2011.
22. World Health Organization IST/ESA. Retrospective documentation of measles outbreak & response in Malawi; 2010.
23. Kisakye A. Documentation of a Measles Outbreak in the Kingdom of Swaziland 2010, World Health Organization.
24. World Health Organization IST/ESA. Retrospective documentation of measles outbreak & response in Lesotho; 2010.
25. World Health Organization. Measles outbreak in Botswana 2010. IST technical support mission; 2010.
26. World Health Organization. Measles outbreak in South Africa, key findings and recommendations. WHO/IST technical support mission; 2009.
27. Minetti A., Kagoli M., Katsulukuta A., et al. Lessons and challenges for measles control from unexpected large outbreak in Malawi. Emerg Infect Dis 2013, 19(2):202-209.
28. Measles outbreaks and progress toward measles preelimination-African region, 2009-2010. MMWR 2011, 60(12):374-378.
29. Burton A., Monasch R., Lautenbach B., et al. WHO and UNICEF estimates of national infant immunization coverage: methods and processes. Bull World Health Organ 2009, 87(July (7)):535-541.
30. Burton A., Kowalski R., Gacic-Dobo M., et al. A formal representation of the WHO and UNICEF estimates of national immunization coverage: a computational logic approach. PLoS One 2012, 7(10):e47806.
31. Yameogo K.R., Perry R.T., Yameogo A., et al. Migration as a risk factor for measles after a mass vaccination campaign Burkina Faso, 2002. Int J Epidemiol 2005, 34(3):556-564.
32. Goodson J.L., Chu S.Y., Rota P.A., et al. Research priorities for global measles and rubella control and eradication. Vaccine 2012, 30(32):4709-4716.
33. Martins C.L., Garly M.L., Bale C., et al. Protective efficacy of standard Edmonston-Zagreb measles vaccination in infants aged 4.5 months: interim analysis of a randomised clinical trial. BMJ 2008, 337:a661.
34. Aaby P., Martins C.L., Garly M.L., et al. The optimal age of measles immunisation in low-income countries: a secondary analysis of the assumptions underlying the current policy. BMJ Open 2012, 2(4).
35. Moss W.J., Monze M., Ryon J.J., et al. Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis 2002, 35(2):189-196.
36. Scott S., Moss W.J., Cousens S., et al. The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis 2007, 45(11):1417-1424.
37. Choudhury S.A., Hatcher F., Berthaud V., et al. Immunity to measles in pregnant mothers and in cord blood of their infants: impact of HIV status and mother's place of birth. J Natl Med Assoc 2008, 100(12):1445-1449.
38. Moss W.J., Scott S., Mugala N., et al. Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis 2007, 196(3):347-355.
39. World Health Organization Measles vaccines: WHO position paper. Wkly Epidemiol Rec 2009, 84(35):349-360.
40. Sartorius B., Cohen C., Chirwa T., et al. Identifying high-risk areas for sporadic measles outbreaks: lessons from South Africa. Bull World Health Organ 2013, 91(3):174-183.
41. Helfand R.F., Moss W.J., Harpaz R., Scott S., Cutts F. Evaluating the impact of the HIV pandemic on measles control and elimination. Bull World Health Organ 2005, 83(5):329-337.
42. McMorrow M.L., Gebremedhin G., van den Heever J., et al. Measles outbreak in South Africa, 2003-2005. S Afr Med J 2009, 99(5):314-319.
43. World Health Organization Regional Office for Africa Measles SIAs Field Guide; 2006.
44. Goodson J.L., Masresha B.G., Wannemuehler K., Uzicanin A., Cochi S. Changing epidemiology of measles in Africa. J Infect Dis 2011, 204(Suppl. 1):S205-S214.
45. World Health Organization. Implementing the Reaching Every District (RED) Approach: A Guide for District Health Management Teams; August 2008. [accessed July 8, 2013]. http://www.who.int/immunization_delivery/systems_policy/AFRO-RED-guide_2008.pdf.
46. Goodson J.L., Masresha B., Dosseh A., et al. Rubella epidemiology in Africa in the prevaccine era, 2002-2009. J Infect Dis 2011, 204(Suppl. 1):S215-S225.
47. World Health Organization. Global Measles and Rubella Strategic Plan 2012-2020; 2012. [accessed March 7, 2013]. http://www.who.int/immunization/newsroom/Measles_Rubella_StrategicPlan_2012_2020.pdf.